Epilepsy: new approach for causal therapy discovered
Epilepsy is primarily treated symptomatically – that is, the majority of the available medications aim to suppress seizures without influencing the underlying causes of the disease.
Using terbium against lymphoma
Radionuclide therapy with the radioactive element terbium could effectively combat lymphoma. This is demonstrated by promising results from experiments carried out at the Paul Scherrer Institute PSI in…
Epilepsy is more common in patients with frontotemporal dementia than expected
According to a recent study, in patients with frontotemporal dementia (FTD), epileptic seizures are significantly more common than previously known. The discovery deepens understanding of the symptoms of…
New visualisation tool helps researchers to target breast cancer dissemination
Cancer cell movement during metastasis is a dynamic process regulated by several different signals. However, the way cells receive, process and respond to these signals has been extremely…
Venous thromboembolism in children: Rivaroxaban effective and safe even with extended use
(VTE) is a life-threatening complication in children with serious underlying conditions such as heart defects or cancer.